Intensive postremission chemotherapy in Taiwanese adults with acute myelogenous leukemia.

Abstract

Intensive postremission chemotherapy has produced disease-free survival comparable to that of bone marrow transplantation in patients with acute myelogenous leukemia (AML), but its efficacy was unknown in Taiwan. We assessed the efficacy of intensive postremission chemotherapy, consisting of high-dose arabinoside-C (HiDAC) with or without transplantation of… (More)

Topics

Cite this paper

@article{Hsu2001IntensivePC, title={Intensive postremission chemotherapy in Taiwanese adults with acute myelogenous leukemia.}, author={H. C. Hsu and J. P. Gau and J. M. Liu and Wilkin Chau and C. H. Ho}, journal={Advances in therapy}, year={2001}, volume={18 2}, pages={67-74} }